- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Carcinoma
Total 76446 results
-
RenJi HospitalUnknownNeoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial CarcinomaChina
-
Cylene PharmaceuticalsCompletedNeuroendocrine Tumors | Carcinoid TumorUnited States
-
Fidia Farmaceutici s.p.a.CompletedONCOFID-P-B in the Intravescical Therapy of Patients With Non-muscle Invasive Cancer of the Bladder.Non-Invasive Papillary Carcinoma of BladderSpain, Germany, Italy
-
Princess Al-Johara Al-Ibrahim Cancer Research CenterCompletedTransitional Cell Carcinoma of the BladderSaudi Arabia
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Gilead SciencesActive, not recruitingMetastatic Urothelial CarcinomaUnited States
-
Acerta Pharma BVMerck Sharp & Dohme LLCCompletedMetastatic Urothelial CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Gastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Stage... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC; Astellas Pharma Inc; Seagen Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | High Grade Urothelial CarcinomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCActive, not recruitingRecurrent Bladder Carcinoma | Stage I Bladder Cancer | Stage 0a Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial CarcinomaUnited States
-
University Hospital, BordeauxTerminatedBladder Carcinoma | Cystectomy | Infiltrative Bladder CarcinomaFrance
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedPeritoneal Neoplasms | Recurrent Ovarian Carcinoma | Recurrent Uterine Corpus Carcinoma | Cervical Carcinoma | Ovarian Carcinoma | Recurrent Cervical Carcinoma | Uterine Corpus Cancer | Vulvar Carcinoma | Primary Peritoneal Carcinoma | Recurrent Vulvar CarcinomaUnited States
-
Zetiq TechnologiesUnknownEvaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine CytologyBladder Cancer Transitional Cell CarcinomaIsrael
-
Yonsei UniversityRecruitingKidney Cancer | Synchronous Neoplasm | Clear Cell Renal Cell Carcinoma MetastaticKorea, Republic of
-
National Cancer Institute (NCI)NRG OncologyTerminatedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Recurrent Uterine Corpus CancerUnited States
-
University of OklahomaGenentech, Inc.CompletedPrimary Peritoneal Carcinoma | Ovarian Carcinosarcoma | Advanced Ovarian CarcinomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnInfiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage IV Bladder Urothelial Carcinoma | Stage III Bladder Urothelial CarcinomaUnited States
-
Foundation MedicineThe Cleveland Clinic; Rush University Medical Center; St. Luke's Hospital and... and other collaboratorsCompletedNeoplasms, Unknown Primary | CUP | Metastatic Disease | Poorly Differentiated Adenocarcinoma | Poorly Differentiated Carcinoma | Squamous Carcinoma Poorly DifferentiatedUnited States
-
University of PittsburghTerminatedSquamous Cell Carcinoma of the Head and Neck | Primary Advanced Carcinoma of the Oral Cavity or OropharynxUnited States
-
THERAPIM PTY LTDNovotech (Australia) Pty LimitedTerminatedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma | High Grade Serious or Endometrioid Carcinoma of the Ovary, Fallopian Tube, or Primary Peritoneal CancerAustralia
-
Shattuck Labs, Inc.Enrolling by invitationOvarian Cancer | Fallopian Tube Cancer | Epithelial Ovarian Cancer | Platinum-resistant Ovarian Cancer | Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal CarcinomaUnited States, United Kingdom, Spain, Canada
-
UroGen Pharma Ltd.CompletedCarcinoma of Urinary Bladder, InvasiveIsrael
-
National Taiwan University HospitalUnknownMetastasis Cervical Lymph Nodes of Unknown Primary CarcinomaTaiwan
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Active, not recruitingStage 0is Bladder Urothelial Carcinoma | Stage I Bladder Urothelial Carcinoma | Stage 0 Bladder Urothelial CarcinomaUnited States
-
Shuguo Zheng, MDCompleted
-
M.D. Anderson Cancer CenterRecruitingCervical Cancer | Cervix Cancer | CarcinomasUnited States
-
National Cancer Institute (NCI)Active, not recruitingSmall Cell Lung Cancer | Extra-Pulmonary Small Cell CarcinomasUnited States
-
Beijing Huanxing Cancer HospitalNewish Technology (Beijing) Co., Ltd.TerminatedUrinary Bladder NeoplasmChina
-
University of MichiganCompletedBladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
Tianjin Medical University Second HospitalRecruitingBladder Urothelial CarcinomaChina
-
Icahn School of Medicine at Mount SinaiCelgeneTerminatedUrinary Bladder NeoplasmsUnited States
-
Henri Mondor University HospitalUnknownPrimary Liver CancersFrance
-
Wren Laboratories LLCEnrolling by invitationNeuroendocrine Tumor | Neuroendocrine Carcinoma | CarcinoidUnited States
-
National Cancer Institute (NCI)CompletedNeuroendocrine Tumor | Gastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | WDHA SyndromeUnited States
-
National Cancer Institute (NCI)CompletedGastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | WDHA SyndromeUnited States
-
UroGen Pharma Ltd.CompletedCarcinoma of Urinary Bladder, SuperficialIsrael, Spain, Italy, Switzerland
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...RecruitingMelanoma | Renal Cell Carcinoma | Breast Cancer | NSCLC | Urinary Bladder Cancer | Squamous Cell Carcinoma of Head and Neck | Small Cell CarcinomaItaly
-
Guru P. SonpavdeQED Therapeutics, Inc.WithdrawnBladder Cancer | Bladder Transitional Cell Carcinoma | Fibroblast Growth Factor Receptor
-
Verity Pharmaceuticals Inc.Not yet recruitingBladder Cancer | Urothelial Carcinoma Bladder | Bladder Cancer Recurrent | Neoplasm Recurrence | Urothelial Carcinoma Recurrent | Non-Invasive Bladder Urothelial Carcinoma
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Texas Appropriation for Rare and Aggressive...RecruitingInvasive Breast Carcinoma | Inflammatory Breast Carcinoma | Second Primary Malignant NeoplasmUnited States
-
British Columbia Cancer AgencyWithdrawnLocally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)Canada
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)WithdrawnGastrointestinal Carcinoid Tumor | Islet Cell Carcinoma
-
University of FloridaNot yet recruitingUrothelial Carcinoma Bladder
-
Association Pour La Recherche des Thérapeutiques...Roche Pharma AGCompletedRecurrent Bladder Cancer | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the BladderFrance, Belgium
-
Yusuf MendaNational Cancer Institute (NCI); National Institutes of Health (NIH); Holden...Not yet recruitingCarcinoid Tumor Lung | Neuroendocrine Tumor of the Lung | Carcinoma, Small-Cell LungUnited States
-
UroGen Pharma Ltd.CompletedBladder Cancer | Urothelial Carcinoma Bladder | Urothelial CarcinomaUnited States, Israel
-
Jonsson Comprehensive Cancer CenterWithdrawnInfiltrating Bladder Urothelial CarcinomaUnited States
-
Janssen Research & Development, LLCCompleted
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingInfiltrating Bladder Urothelial Carcinoma | Stage II Bladder Urothelial Carcinoma | Stage III Bladder Urothelial CarcinomaUnited States
-
Seoul National University HospitalUnknown
-
Matthew GalskyCelgeneTerminatedBladder CancerUnited States